|

ch14.18/CHO Clinical Trials

1 actively recruiting trial

Also known as: Dinutuximab beta EUSA, Qarziba®, anti GD2 antibody

Other1 trial

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.